For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220613:nRSM6910Oa&default-theme=true
RNS Number : 6910O CVS Group plc 13 June 2022
13 June 2022
CVS Group Plc
("CVS", the "Company" or the "Group")
Postponement to Capital Markets Day
In light of the proposed industrial action in the UK next week and the
expected travel disruption that this will cause, CVS has taken the decision to
postpone its Capital Markets Day, which was due to take place on 22 June 2022.
The event will be rescheduled for the autumn, with the revised date to be
confirmed in due course.
Contacts:
CVS Group plc via MHP Communications
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Singer Capital Markets (Nominated Adviser & Broker) +44 20 7496 3000
Aubrey Powell / Jen Boorer / Rachel Hayes
MHP Communications (Financial PR) +44 20 3128 8549
Andrew Jaques / Simon Hockeridge / Rachel Farrington / Charles Hirst
About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )
CVS Group is an AIM-quoted fully-integrated provider of veterinary services in
the UK, with practices in the Netherlands and the Republic of Ireland. CVS is
focused on providing high quality clinical services to its customers and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.
The Group has c.500 veterinary practices across its three markets, including
eight specialist referral hospitals and 35 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").
The Group employs c.7,900 personnel, including c.2,100 veterinary surgeons
and c.2,900 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCGPUMAQUPPGWW